Allos is trading at BRL 24.01, down 31.67%, with no verified catalyst identified. - Allos’s October 23 announcement concerned a Kinea fund transaction. A report said the fund’s maximum fundraising was reduced from R$1.97 billion to R$1 billion, citing revised market conditions, but did not link the change to the decline. - Supplied U.S. indices are higher, so broad-market weakness does not explain the drop. Available evidence does not establish a specific catalyst or trading-volume context.